Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUBoSS: Early Botox for Post-Stroke Arm Spasticity
NCT01882556Phase 2Completed
- Sponsor
- Sandwell and West Birmingham NHS Trust
- Start
- Jan 2012
- Primary completion
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in Spasticity, sponsored by Sandwell and West Birmingham NHS Trust. Primary endpoint: Action Research Arm Test at 6 months. Started Jan 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT01882556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01882556.